Zefiro Founder and Former Chairman Updates Shareholders on Recent Developments at the Company

Executive Summary

• Dr. Talal A. Debs alleges that Zefiro Methane Corp.’s board is entrenching current management through enhanced executive compensation, “golden parachutes,” and insider share purchases ahead of a proxy contest.
• The board approved change‑of‑control payments that could cost up to US $3 million (≈20% of market cap) if triggered in Q1 2026, and settled $407,856 of debt by issuing 1.13 M shares plus 400 k stock options, diluting existing shareholders.
• The annual shareholder meeting has been delayed until March 4 2026, denying shareholders a timely vote; Dr. Debs is preparing a dissident information circular and may solicit proxies on behalf of his XMC group (≈27.5% ownership).

Key Details

• Insider Purchases:
• Four board members bought a total of 723,000 shares (Dec 1 2025 release).
• Director Daryl Heald purchased 147,500 shares on Nov 25, representing 89% of Canadian trading volume that day; share price rose $0.04 (+14%).
• Executive Compensation Changes:
• Four senior executives (including Interim CEO Catherine Flax and Interim CFO Michael Downs) entered “single‑trigger” change‑of‑control agreements on June 4 2025.
• Potential payout in Q1 2026 could reach US $3 million, roughly 20% of Zefiro’s market capitalization.
• Debt Settlement Dilution:
• On Nov 28 2025 the company issued 1,127,273 common shares and granted 400,000 stock options to settle $407,856 of debt at a deemed price of C$0.275 per share (close price C$0.31).
• Annual Meeting Delay:
• Shareholder requisition filed Nov 20 2025 demanded an annual meeting by Dec 31 2025; company obtained exemption and set the meeting for March 4 2026 (press release Dec 12 2025).
• Shareholder Ownership & Proxy Plans:
• Dr. Debs, via XMC and personal holdings, controls 20,914,750 shares (27.488% of outstanding).
• He intends to file a dissident information circular and may solicit proxies; 500,000 personally held shares will not be voted by him.
• Financial Results Reference:
• Company reported “solid” Q1 2026 results (June‑30 year‑end), but Dr. Debs argues the performance reflects prior management actions and masks governance concerns.

Notable Quotes

“These actions appear intended to improve the Board’s own position in the face of an upcoming proxy contest… The Board has been denying shareholders the opportunity to vote on the future of their own company by failing to hold an annual meeting in 2025 as required by law.” – Dr. Talal A. Debs, Founder and Director, Zefiro Methane Corp.

Materiality Assessment: Material – Negative (significant governance concerns, potential large executive payouts, shareholder dilution, and delayed voting rights.)